Only in SMA type 1 patients, longer disease duration significantly correlated with lower baseline levels of T‐Tau, NfL and p‐NfH and lower changes of NfL levels from baseline to treatment day 63, 180 and 300. Here, NEFL is linked to spinal muscular atrophy, type 1.